CRAZX
Price
$11.36
Change
-$0.24 (-2.07%)
Updated
Jun 5 closing price
Net Assets
2.56B
GAGIX
Price
$37.50
Change
-$0.34 (-0.90%)
Updated
Jun 5 closing price
Net Assets
73.12M
Interact to see
Advertisement

CRAZX vs GAGIX

Header iconCRAZX vs GAGIX Comparison
Open Charts CRAZX vs GAGIXBanner chart's image
CRAZX vs GAGIX Comparison Chart in %
View a ticker or compare two or three
VS
CRAZX vs. GAGIX commentary
Jun 07, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRAZX is a Hold and GAGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CRAZX has more cash in the bank: 2.56B vs. GAGIX (73.1M). CRAZX pays higher dividends than GAGIX: CRAZX (2.63) vs GAGIX (2.08). CRAZX was incepted earlier than GAGIX: CRAZX (14 years) vs GAGIX (18 years). GAGIX (1.35) is less costly to investors than CRAZX (0.81). CRAZX is a more actively managed with annual turnover of: 186.00 vs. GAGIX (5.00). GAGIX has a lower initial minimum investment than CRAZX: GAGIX (1000) vs CRAZX (2000). CRAZX annual gain was more profitable for investors over the last year : 18.43 vs. GAGIX (15.23). GAGIX return over 5 years is better than : 19.01 vs. CRAZX (10.27).
CRAZXGAGIXCRAZX / GAGIX
Total Expense Ratio0.810.9090%
Annual Report Gross Expense Ratio0.811.3560%
Fund Existence14 years18 years-
Gain YTD7.2714.836150%
Front LoadN/AN/A-
Min. Initial Investment20001000200%
Min. Initial Investment IRAN/AN/A-
Net Assets2.56B73.1M3,497%
Annual Yield % from dividends2.632.08126%
Returns for 1 year18.4315.23121%
Returns for 3 years40.1233.34120%
Returns for 5 years10.2719.0154%
Returns for 10 years43.4888.3249%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRFH2.22N/A
N/A
Barfresh Food Group
LAD288.84-1.76
-0.61%
Lithia Motors
TRS39.17-0.38
-0.96%
TriMas Corp
GEV933.61-29.72
-3.09%
GE Vernova
DMAC5.64-0.20
-3.42%
DiaMedica Therapeutics